Evidence-based drug therapy for chronic heart failure / (Record no. 85427)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01735nam a2200229Ia 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 230724s2002 xx 000 0 und d |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Zannad, F. |
| 9 (RLIN) | 7850 |
| 245 #0 - TITLE STATEMENT | |
| Title | Evidence-based drug therapy for chronic heart failure / |
| Statement of responsibility, etc. | F. Zannad |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Date of publication, distribution, etc. | April 2002 |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| 337 ## - MEDIA TYPE | |
| Media type term | unmediated |
| 338 ## - CARRIER TYPE | |
| Carrier type term | volume |
| 440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE | |
| Number of part/section of a work | 4 : Supplement D, pages D66-D72 |
| Title | European Heart Journal Supplements |
| 9 (RLIN) | 7851 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Evidence-based medicine requires that clinical benefits should be evaluated by ‘hard’ end-points (i.e. morbidity and mortality). ‘Soft’ intermediate end-points such as haemodynamic improvement are not always associated with improvements in quality of life or survival. Changes in clinical practice should be based on statistically significant effects on primary end-points, and not on subgroup analyses. Angiotensin-converting enzyme (ACE) inhibitors are of demonstrated benefit in all forms of congestive heart failure (CHF) with systolic dysfunction, when used at optimal doses. Beta-blockers confer additional quality of life and survival benefits. Spironolactone may be added in patients with severe CHF. In patients who are intolerant of ACE inhibitors, angiotensin II receptor blockers may be useful as a substitute. Despite the overwhelming data available, evidence-based recommendations for drug therapy are not widely implemented in CHF. Education and implementation programmes should be designed with the objective of combating ignorance, incredulity and inaction. |
| 521 ## - TARGET AUDIENCE NOTE | |
| Target audience note | Nursing. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Clinical trials. |
| 9 (RLIN) | 7852 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drug therapy. |
| 9 (RLIN) | 6446 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Guidelines. |
| 9 (RLIN) | 7853 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Heart failure. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Articles |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Library of Congress Classification | Manila Tytana Colleges Library | Manila Tytana Colleges Library | REFERENCE SECTION | 07/24/2023 | 07/24/2023 | 07/24/2023 | Articles |